CEO: Scott Garland

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Portola Pharmaceuticals Inc is engaged in the healthcare sector. It develops & commercializes novel therapeutics to combat thrombosis, hematologic disorders & inflammation.


Key numbers

Market Capitalization:2077728390
Shares Outstanding: 76359000
Float: 74856865.752
Next Earning Date:2020-02-26
TTm EPS: -4.1483
TTm Dividend Rate:
200 days moving average:29.74
50 days moving average: 28.43
One day percent Change: 1.27



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,